Return On Assets of Skye Bioscience, Inc. from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Skye Bioscience, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • Skye Bioscience, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -89%, a 188% decline year-over-year.
  • Skye Bioscience, Inc. annual Return On Assets for 2024 was -32%, a 93% increase from 2023.
  • Skye Bioscience, Inc. annual Return On Assets for 2023 was -438%, a 36% decline from 2022.
  • Skye Bioscience, Inc. annual Return On Assets for 2022 was -323%, a 207% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Skye Bioscience, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -89% -58% -188% 01 Jul 2025 30 Sep 2025
Q2 2025 -62% +18% +23% 01 Apr 2025 30 Jun 2025
Q1 2025 -43% +78% +65% 01 Jan 2025 31 Mar 2025
Q4 2024 -32% +407% +93% 01 Oct 2024 31 Dec 2024
Q3 2024 -31% +516% +94% 01 Jul 2024 30 Sep 2024
Q2 2024 -81% +372% +82% 01 Apr 2024 30 Jun 2024
Q1 2024 -120% +281% +70% 01 Jan 2024 31 Mar 2024
Q4 2023 -438% -116% -36% 01 Oct 2023 31 Dec 2023
Q3 2023 -547% -352% -181% 01 Jul 2023 30 Sep 2023
Q2 2023 -453% -325% -254% 01 Apr 2023 30 Jun 2023
Q1 2023 -401% -291% -265% 01 Jan 2023 31 Mar 2023
Q4 2022 -323% -217% -207% 01 Oct 2022 31 Dec 2022
Q3 2022 -194% -75% -63% 01 Jul 2022 30 Sep 2022
Q2 2022 -128% +28% +18% 01 Apr 2022 30 Jun 2022
Q1 2022 -110% +92% +46% 01 Jan 2022 31 Mar 2022
Q4 2021 -105% +226% +68% 01 Oct 2021 31 Dec 2021
Q3 2021 -119% -108% -944% 01 Jul 2021 30 Sep 2021
Q2 2021 -156% +176% +53% 01 Apr 2021 30 Jun 2021
Q1 2021 -202% -923% -128% 01 Jan 2021 31 Mar 2021
Q4 2020 -331% -368% -1008% 01 Oct 2020 31 Dec 2020
Q3 2020 -11% +338% +97% 01 Jul 2020 30 Sep 2020
Q2 2020 -332% -69% -26% 01 Apr 2020 30 Jun 2020
Q1 2020 722% +1763% 01 Jan 2020 31 Mar 2020
Q4 2019 37% +959% 01 Oct 2019 31 Dec 2019
Q3 2019 -349% +437% +56% 01 Jul 2019 30 Sep 2019
Q2 2019 -263% +523% +67% 01 Apr 2019 30 Jun 2019
Q1 2019 -1042% -159% -18% 01 Jan 2019 31 Mar 2019
Q4 2018 -922% -304% -49% 01 Oct 2018 31 Dec 2018
Q3 2018 -786% +26% +3.2% 01 Jul 2018 30 Sep 2018
Q2 2018 -786% -20% -2.6% 01 Apr 2018 30 Jun 2018
Q1 2018 -883% -474% -116% 01 Jan 2018 31 Mar 2018
Q4 2017 -618% -332% -116% 01 Oct 2017 31 Dec 2017
Q3 2017 -812% -668% -463% 01 Jul 2017 30 Sep 2017
Q2 2017 -766% -662% -636% 01 Apr 2017 30 Jun 2017
Q1 2017 -409% -209% -104% 01 Jan 2017 31 Mar 2017
Q4 2016 -286% -79% -38% 01 Oct 2016 31 Dec 2016
Q3 2016 -144% +235% +62% 01 Jul 2016 30 Sep 2016
Q2 2016 -104% +696% +87% 01 Apr 2016 30 Jun 2016
Q1 2016 -200% +485% +71% 01 Jan 2016 31 Mar 2016
Q4 2015 -207% +413% +67% 01 Oct 2015 31 Dec 2015
Q3 2015 -379% -115% -43% 01 Jul 2015 30 Sep 2015
Q2 2015 -800% -662% -478% 01 Apr 2015 30 Jun 2015
Q1 2015 -685% -642% -1509% 01 Jan 2015 31 Mar 2015
Q4 2014 -620% -2105% 01 Oct 2014 31 Dec 2014
Q3 2014 -264% 01 Jul 2014 30 Sep 2014
Q2 2014 -138% 01 Apr 2014 30 Jun 2014
Q1 2014 -43% 01 Jan 2014 31 Mar 2014
Q4 2013 1485%* 01 Nov 2013 31 Jan 2014

Skye Bioscience, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -32% +407% +93% 01 Jan 2024 31 Dec 2024
2023 -438% -116% -36% 01 Jan 2023 31 Dec 2023
2022 -323% -217% -207% 01 Jan 2022 31 Dec 2022
2021 -105% +226% +68% 01 Jan 2021 31 Dec 2021
2020 -331% -368% -1008% 01 Jan 2020 31 Dec 2020
2019 37% +959% 01 Jan 2019 31 Dec 2019
2018 -922% -304% -49% 01 Jan 2018 31 Dec 2018
2017 -618% -332% -116% 01 Jan 2017 31 Dec 2017
2016 -286% -79% -38% 01 Jan 2016 31 Dec 2016
2015 -207% +413% +67% 01 Jan 2015 31 Dec 2015
2014 -620% -532% -608% 01 Jan 2014 31 Dec 2014
2013 -88% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.